Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA minor revision identifier on the page footer was updated from version v3.5.2 to v3.5.3. This reflects a behind-the-scenes release rather than a change to the study’s content.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check55 days agoChange DetectedPage revision updated to v3.5.0; added Genetic and Rare Diseases Information Center resources and the Hepatocellular carcinoma term.SummaryDifference0.2%

- Check69 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page revision label was updated from v3.4.0 to v3.4.1, indicating a minor maintenance update that does not affect the study details.SummaryDifference0.1%

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.